Blockade of interferon‐γ‐inducible protein‐10 attenuates chronic experimental colitis by blocking cellular trafficking and protecting intestinal epithelial cells

The role of chemokines, especially CXCL10/interferon‐γ‐inducible protein 10 kDa (IP‐10), a chemokine to attract CXCR3+ T‐helper 1‐type CD4+ T cells, is largely unknown in the pathophysiology of inflammatory bowel disease; ulcerative colitis and Crohn's disease. The authors have earlier shown that IP‐10 neutralization protected mice from acute colitis by protecting crypt epithelial cells of the colon. To investigate the therapeutic effect of neutralization of IP‐10 on chronic colitis, an anti‐IP‐10 antibody was injected into mice with newly established murine AIDS (MAIDS) colitis. Anti‐IP‐10 antibody treatment reduced the number of colon infiltrating cells when compared to those mice given a control antibody. The treatment made the length of the crypt of the colon greater than control antibody. The number of Ki67+ proliferating epithelial cells was increased by the anti‐IP‐10 antibody treatment. Terminal deoxynucleotidyl transferase‐mediated dUTP nick‐end labeling (TUNEL)+ apoptotic cells were observed in the epithelial cells of the luminal tops of crypts in control MAIDS colitis, whereas TUNEL+ apoptotic epithelial cells were rarely observed with anti‐IP‐10 antibody treatment. In conclusion, blockade of IP‐10 attenuated MAIDS colitis through blocking cellular trafficking and protecting intestinal epithelial cells, suggesting that IP‐10 plays a key role in the development of inflammatory bowel disease as well as in chronic experimental colitis.

[1]  F. Powrie,et al.  Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation , 2006, Immunological reviews.

[2]  Kenji Suzuki,et al.  Role of IP-10/CXCL10 in the progression of pancreatitis-like injury in mice after murine retroviral infection. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[3]  M. Neurath,et al.  Transforming growth factor β induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis , 2005, Gut.

[4]  Kenji Suzuki,et al.  Kinetic analysis of the development of pancreatic lesions in mice infected with a murine retrovirus. , 2003, Clinical immunology.

[5]  D. Taub,et al.  Inhibition of IFN-γ-Inducible Protein-10 Abrogates Colitis in IL-10−/− Mice 1 , 2003, The Journal of Immunology.

[6]  Kenji Suzuki,et al.  Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival , 2002, European journal of immunology.

[7]  N. Ogawa,et al.  Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome. , 2002, Arthritis and rheumatism.

[8]  R. Ravid,et al.  Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system , 2002, Journal of Neuroimmunology.

[9]  K. Matsushima,et al.  Neutralization of IFN‐inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis , 2002, European journal of immunology.

[10]  M. Leach,et al.  Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL‐10– / – mice and Rag‐2– / – mice reconstituted with CD4+CD45RBhigh T cells , 2001, European journal of immunology.

[11]  H. Kawachi,et al.  Analysis of cytokine production in the colon of nude mice with experimental colitis induced by adoptive transfer of immunocompetent cells from mice infected with a murine retrovirus. , 2000, Clinical immunology.

[12]  C. Mackay,et al.  Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. , 1998, Immunology today.

[13]  M. Baggiolini.  Chemokines and leukocyte traffic , 1998, Nature.

[14]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[15]  H. Asakura,et al.  Induction of intestinal lesions in nu/nu mice induced by transfer of lymphocytes from syngeneic mice infected with murine retrovirus , 1997, Gut.

[16]  Y. Tominaga,et al.  Expression of IFN-inducible protein-10 in chronic hepatitis. , 1997, Journal of immunology.

[17]  J. Farber.  Mig and IP‐10: CXC chemokines that target lymphocytes , 1997, Journal of leukocyte biology.

[18]  F. Powrie,et al.  T cells in inflammatory bowel disease: protective and pathogenic roles. , 1995, Immunity.

[19]  C. Elson,et al.  Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. , 1994, Gastroenterology.

[20]  H. Asakura,et al.  Exocrinopathy resembling Sjögren's syndrome induced by a murine retrovirus. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[21]  P. Jolicoeur.  Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogenesis , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  H. Morse,et al.  Aberrant expression of cytokine genes in peritoneal macrophages from mice infected with LP-BM5 MuLV, a murine model of AIDS. , 1991, Journal of immunology.

[23]  S. Klinken,et al.  Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS. , 1988, Journal of immunology.

[24]  J. Ravetch,et al.  Biochemical characterization of a gamma interferon-inducible cytokine (IP-10) , 1987, The Journal of experimental medicine.

[25]  H. Morse,et al.  Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice , 1985, The Journal of experimental medicine.

[26]  D. Taub,et al.  Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10-/- mice. , 2003, Journal of immunology.

[27]  M. Baggiolini,et al.  Short Communication Increased Expression of IP-10, IL-8, MCP-1, and MCP-3 in Ulcerative Colitis , 1999 .